Status:

COMPLETED

The Mixed Phenotype of Asthma and COPD: the Overlap Syndrome

Lead Sponsor:

Laval University

Conditions:

Asthma

COPD

Eligibility:

All Genders

45+ years

Brief Summary

RATIONALE: In asthmatic subjects, smoking can lead to several changes in disease characterictics. in smokers of more than 20 pack-years, chronic obstructive pulmonary disease (COPD) can be associated...

Eligibility Criteria

Inclusion

  • ALL SUBJECTS
  • Subjects aged 45 years and older.
  • Free of any other respiratory condition, except for asthma and/or COPD, which may interfere with the tests.
  • Asthma that requires a baseline treatment with inhaled corticosteroids and/or additional asthma medication.
  • Free of respiratory infection in the 4 weeks preceding the study.
  • No changes in the asthma and COPD-related medications in the 4 weeks preceding the study.
  • If female, not pregnant (or lactating).
  • Able to adhere to study procedures.
  • Able and willing to provide written informed consent to participate in the study, in accordance with international conference on harmonization (ICH) good clinical practice (GCP) requirements.
  • ACOS SUBJECTS
  • 1\. Smokers or ex-smokers of at least 20 pack-years. 2. With an IRAO (see definitions section). IRAO SUBJECTS
  • Long-life non-smokers or ex-smokers defined as someone who smoked less than 5 pack-years and who completely stopped smoking for at least 12 months before inclusion in the study.
  • With an IRAO.

Exclusion

  • ALL SUBJECTS
  • With COPD without a past diagnosis of asthma.
  • Unstable respiratory or non-respiratory condition.
  • Any active chronic inflammatory disease.
  • Any evidence of malignancy (active and/or treated) within the previous 5 years.
  • Any significant concomitant illness or injury that would interfere with the subject's participation in the study.
  • Any history of bronchial thermoplasty. IRAO SUBJECTS
  • <!-- -->
  • Use of any nicotine containing product within 1 year prior to study entry or a smoking history of \> 5 pack-years.

Key Trial Info

Start Date :

March 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

115 Patients enrolled

Trial Details

Trial ID

NCT03817333

Start Date

March 1 2014

End Date

December 1 2017

Last Update

January 25 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut universitaire de cardiologie et de pneumologie de Québec

Québec, Quebec, Canada, G1V 4G5